Peyronie's Disease: Evolving Surgical Management and the Role of Phosphodiesterase 5 Inhibitors

Peyronie's disease (PD) is a fibrotic disorder of the tunica albuginea of the penis. It is characterized by different degrees of penile curvature and sexual dysfunction. Several medical treatments have been employed to manage the disorder, with variable success rates. Surgical therapy is reserv...

Full description

Saved in:
Bibliographic Details
Main Authors: Tariq F. Al-Shaiji, Gerald B. Brock
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/tsw.2009.101
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561786882097152
author Tariq F. Al-Shaiji
Gerald B. Brock
author_facet Tariq F. Al-Shaiji
Gerald B. Brock
author_sort Tariq F. Al-Shaiji
collection DOAJ
description Peyronie's disease (PD) is a fibrotic disorder of the tunica albuginea of the penis. It is characterized by different degrees of penile curvature and sexual dysfunction. Several medical treatments have been employed to manage the disorder, with variable success rates. Surgical therapy is reserved for patients with severe penile deformity that fails to improve with medical treatment and impedes coital function. The advantages and disadvantages of various surgical approaches have long been debated. Herein, we describe the evolving surgical techniques for PD using knowledge obtained from the contemporary literature. In addition, we discuss the emerging data regarding the role of phosphodiesterase 5 inhibitors in the management of PD.
format Article
id doaj-art-a4675f7e511840fdb9ded3b077c16531
institution Kabale University
issn 1537-744X
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-a4675f7e511840fdb9ded3b077c165312025-02-03T01:24:16ZengWileyThe Scientific World Journal1537-744X2009-01-01982284510.1100/tsw.2009.101Peyronie's Disease: Evolving Surgical Management and the Role of Phosphodiesterase 5 InhibitorsTariq F. Al-Shaiji0Gerald B. Brock1Division of Urology, Department of Surgery, University of Western Ontario, London, ON, CanadaDivision of Urology, Department of Surgery, University of Western Ontario, London, ON, CanadaPeyronie's disease (PD) is a fibrotic disorder of the tunica albuginea of the penis. It is characterized by different degrees of penile curvature and sexual dysfunction. Several medical treatments have been employed to manage the disorder, with variable success rates. Surgical therapy is reserved for patients with severe penile deformity that fails to improve with medical treatment and impedes coital function. The advantages and disadvantages of various surgical approaches have long been debated. Herein, we describe the evolving surgical techniques for PD using knowledge obtained from the contemporary literature. In addition, we discuss the emerging data regarding the role of phosphodiesterase 5 inhibitors in the management of PD.http://dx.doi.org/10.1100/tsw.2009.101
spellingShingle Tariq F. Al-Shaiji
Gerald B. Brock
Peyronie's Disease: Evolving Surgical Management and the Role of Phosphodiesterase 5 Inhibitors
The Scientific World Journal
title Peyronie's Disease: Evolving Surgical Management and the Role of Phosphodiesterase 5 Inhibitors
title_full Peyronie's Disease: Evolving Surgical Management and the Role of Phosphodiesterase 5 Inhibitors
title_fullStr Peyronie's Disease: Evolving Surgical Management and the Role of Phosphodiesterase 5 Inhibitors
title_full_unstemmed Peyronie's Disease: Evolving Surgical Management and the Role of Phosphodiesterase 5 Inhibitors
title_short Peyronie's Disease: Evolving Surgical Management and the Role of Phosphodiesterase 5 Inhibitors
title_sort peyronie s disease evolving surgical management and the role of phosphodiesterase 5 inhibitors
url http://dx.doi.org/10.1100/tsw.2009.101
work_keys_str_mv AT tariqfalshaiji peyroniesdiseaseevolvingsurgicalmanagementandtheroleofphosphodiesterase5inhibitors
AT geraldbbrock peyroniesdiseaseevolvingsurgicalmanagementandtheroleofphosphodiesterase5inhibitors